Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 4/20 | 0.44 |
| ▸ | LPL | P06858 | 3/20 | 0.44 |
| ▸ | PDK2 | Q15119 | 7/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.31 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.31 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.30 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17142004 | 0.91 | LIPG (0.44) | LIPGLPLPDK2 | |
| SCHEMBL17142003 | 0.86 | LPL (0.37) | LIPGLPLPDK2 | |
| SCHEMBL20961187 | 0.84 | LPL (0.34) | LIPGLPLPDK2 | |
| SCHEMBL21995628 | 0.83 | LPL (0.41) | LIPGLPLPDK2 | |
| SCHEMBL17268985 | 0.83 | LIPG (0.53) | LIPGLPLPDK2PRMT5WDR77 | |
| SCHEMBL12442308 | 0.83 | LPL (0.38) | LIPGLPLPDK2PRMT5WDR77 | |
| SCHEMBL29738313 | 0.83 | LPL (0.38) | LIPGLPLPDK2PRMT5WDR77 | |
| SCHEMBL25799114 | 0.82 | LIPG (0.56) | LIPGLPLHSD17B1HSD17B2 | |
| SCHEMBL17142015 | 0.81 | LPL (0.44) | LIPGLPLPDK2 | |
| SCHEMBL12181063 | 0.81 | LPL (0.37) | LIPGLPLPDK2PRMT5WDR77 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106164055-B | Heterocyclic compound and organic light-emitting device comprising same | 株式会社LG化学 | 2019-12-27 | — | — | CN | disclosed |
| US-10381572-B2 | Heterocyclic compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2019-08-13 | — | — | US | disclosed |
| US-20170018718-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2017-01-19 | — | — | US | disclosed |
| WO-2015152651-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2015-10-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10381572-B2 | Heterocyclic compound and organic light-emitting element comprising same | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885PDK2 2847/4885 |
| US-20170018718-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME | CRY1, CRY2, PER2 | LIPG 2731/4885LPL 2062/4885PDK2 2847/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.